Surgnova Healthcare Technologies (Zhejiang) Co.,Ltd.
Surgnova Healthcare Technologies was founded in 2015. The core founding team has decades of experience in R&D, production, marketing and other related fields in international medical giants. The company is specialized in minimally invasive surgery and tumor interventional treatment. It is committed to providing the world with cutting-edge surgical systems and instruments that are easy to use, high-quality, reliable and affordable by innovative technology and highly efficient operations.
Surgnova owns an R&D center with 10+laboratories of electronics, machinery, optics, acoustics, robotics, animal tissue, reliability testing etc. Up to now, Surgnova has 40+ Chinese national invention patents and 10+PCT international invention patents. Surgnova owns a nearly 10,000㎡medical equipment manufacturing center with the MD GMP requirement in High-tech Entrepreneurship Park at Cixi, Zhejiang, including a 2,000㎡Class-100,000 clean room. With an overseas business operating center in Shenzhen, Surgnova quickly responds to global customer needs and delivers China's high-end minimally invasive surgical total solutions to the world.
At present, Surgnova has established three platforms: endoscopy platform, energy surgery platform and tumor ablation platform. They provide superior quality of minimally invasive surgical solution to the globe. The products mainly include 2D & 3D video endoscopy system, gas insufflator, ultrasonic scalpel system, ultrasonic surgical & electrosurgical system, powered endoscopic staplers, electroporation system, microwave ablation system, radiofrequency ablation system etc., which cover all mainstream equipments and instruments throughout minimally invasive surgery. Among them, many products have obtained CE, NMPA, FDA certification. The products and services of Surgnova have entered dozens of countries and regions in Europe, America, Asia and Africa.